The Deal
Monday, November 23, 
3:57 pm

Prescription for growth: CVS Caremark acquires Longs Drugs

Posted on August 12, 2008 at 5:56 PM
Filed under: Acquisitions | Growth Strategy
Tagged: , , , , ,
[ Share ]  [ E-mail ]  [ Leave a Comment ]
presription.gifAs part of its growth strategy CVS Caremark Corp. has acquired Longs Drug Stores for $2.9 billion.

The acquisition will add 521 more drugstores in California, Hawaii, Nevada and Arizona to make the grand total of CVS Caremark's drugstores 6,800 in 41 states. The deal will also add to its prescription benefits management services through Long's Rx America subsidiary. CVS has been concentrating on the PBM business -- which sells drugs directly to individual customers and negotiates with drug companies on behalf of employers, insurers, unions, government employee groups and managed-care organizations, as Cheryl Meyer notes.

Competitor Walgreen Co. isn't in the PBM business, but it has its own niche. Walgreen has been expanding by acquiring in the specialty pharmacies and services division. In June Walgreen announced it had acquired CuraScript Infusion Pharmacy Inc., a home infusion pharmacy division that provides treatments for immune deficiency, chemotherapy and pain management. Walgreen also acquired OptionCare Enterprises in July 2007 for $850 million in cash. - Maria Woehr

Join Corporate Dealmaker's LinkedIn forum

Comments
Post a comment


Search


Search For

Corporate Dealmaker Video


Deal Economy 2010: Cisco's Hooper on M&A strategy

Cisco Systems Inc's Hooper on how transactions have transformed the company's business.
Decade of The Deal


Movers & Shakers


Juergen Lasowski
Onyx Pharmaceuticals Inc.

Edward Swallow
Northrop Grumman Corp.

Owen Mahoney
Outspark

Alice Kim
FLO TV Inc.

Eric Hausler
Isle of Capri Casinos Inc.
Juergen Lasowski, Onyx Pharmaceuticals Inc.
Edward Swallow, Northrop Grumman Corp.
Owen Mahoney, Outspark
Alice Kim, FLO TV Inc.
Eric Hausler, Isle of Capri Casinos Inc.


COMPLETE MOVERS & SHAKERS ARCHIVES

The Magazine


MACDdec1cover.gifAnd the winners are...
Even in a period when things like toxic credit default swaps and noxious structured investment vehicles dominate the conversation in many parts of the deal community, people are still willing to take the time to recognize skill and achievement in the strategic transactions that help those companies adapt and grow.
View the complete issue


Last Issue
Archives
Suggest a topic
Purchase a reprint
Subscribe to The Deal


Monthly Archives


Syndicate

Contributors

footspacer.jpg footspacer.jpg footspacer.jpg footspacer.jpg footspacer.jpg


©Copyright 2009, The Deal, LLC. All rights reserved. Please send all technical questions, comments or concerns to the Webmaster.